3,4-dihydroxyphenylacetic acid has been researched along with nefiracetam in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dell'Anna, E; Kojima, H; Lindqvist, E; Luthman, J; Olson, L; Shiotani, T; Tachizawa, H | 1 |
Kojima, H; Taniguchi, K; Watabe, S | 1 |
Kameyama, T; Mamiya, T; Nabeshima, T; Shiotani, T; Tanaka, T; Yamada, K | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and nefiracetam
Article | Year |
---|---|
Effects of DM-9384, a pyrrolidone derivative, on ischemia-induced changes in the central monoamine systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain Chemistry; Brain Ischemia; Central Nervous System Agents; Gerbillinae; Homovanillic Acid; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Pyrrolidinones; Serotonin | 1992 |
Improvement of impaired brain monoamine metabolism by the cognition-enhancing agent nefiracetam after microsphere-induced cerebral embolism in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Biogenic Monoamines; Brain Chemistry; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Intracranial Embolism and Thrombosis; Male; Microspheres; Nerve Tissue Proteins; Psychotropic Drugs; Pyrrolidinones; Rats; Rats, Wistar; Serotonin | 1994 |
Improvement by nefiracetam of beta-amyloid-(1-42)-induced learning and memory impairments in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amyloid beta-Peptides; Animals; Avoidance Learning; Biogenic Monoamines; Choline O-Acetyltransferase; Corpus Striatum; Dopamine; Frontal Lobe; Hippocampus; Homovanillic Acid; Learning; Learning Disabilities; Male; Maze Learning; Memory Disorders; Motor Activity; Peptide Fragments; Psychotropic Drugs; Pyrrolidinones; Rats; Rats, Wistar | 1999 |